Walvax Biotechnology Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 599.75 million compared to CNY 833.27 million a year ago. Revenue was CNY 599.75 million compared to CNY 833.27 million a year ago.

Net income was CNY 14.13 million compared to CNY 171.99 million a year ago. Basic earnings per share from continuing operations was CNY 0.0088 compared to CNY 0.1074 a year ago. Diluted earnings per share from continuing operations was CNY 0.0088 compared to CNY 0.1074 a year ago.